Antibody Discovery News and Research

RSS
Sorrento Therapeutics completes construction of fully human mAbs library

Sorrento Therapeutics completes construction of fully human mAbs library

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

AVEO Pharmaceuticals to present preclinical data from translational research platform at AACR 2010

BioInvent International, HGS announce collaboration to develop therapeutic monoclonal antibodies

BioInvent International, HGS announce collaboration to develop therapeutic monoclonal antibodies

HGS, BioInvent International AB to discover, develop and commercialize therapeutic monoclonal antibodies

HGS, BioInvent International AB to discover, develop and commercialize therapeutic monoclonal antibodies

Sorrento Therapeutics, Scripps Research Institute announce antibody development collaboration

Sorrento Therapeutics, Scripps Research Institute announce antibody development collaboration

Adimab announces initiation of research collaborations with two other companies

Adimab announces initiation of research collaborations with two other companies

Symphogen announces the opening of its United States headquarters in Princeton

Symphogen announces the opening of its United States headquarters in Princeton

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

Adimab announces the completion of Series D financing

Adimab announces the completion of Series D financing

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

Two new antibodies for targeting HIV virus discovered

Two new antibodies for targeting HIV virus discovered

Oxford BioTherapeutics and GSK form alliance to develop cancer therapeutic antibodies

Oxford BioTherapeutics and GSK form alliance to develop cancer therapeutic antibodies

Xencor and CSL Limited establish antibody optimization collaboration

Xencor and CSL Limited establish antibody optimization collaboration

Vaccinex antibody licensed to GlaxoSmithKline

Vaccinex antibody licensed to GlaxoSmithKline

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek announces agreement for development of antibodies to treat prostate cancer

Vaccinex receives new European patent for antibody discovery technology

Vaccinex receives new European patent for antibody discovery technology

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Morphotek issued new U.S patent for method to enhance the affinity of monoclonal antibodies

Pfizer acquires antibody discovery company Bioren

Pfizer acquires antibody discovery company Bioren

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.